<?xml version="1.0" encoding="UTF-8"?>
<ref id="B93">
 <label>93.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Petersen</surname>
    <given-names>KA</given-names>
   </name>
   <name>
    <surname>Matthiesen</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Agger</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Kongerslev</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Thiel</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Cornelissen</surname>
    <given-names>K</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin</article-title>. 
  <source>J Clin Immunol.</source> (
  <year>2006</year>) 
  <volume>26</volume>:
  <fpage>465</fpage>â€“
  <lpage>75</lpage>. 
  <pub-id pub-id-type="doi">10.1007/s10875-006-9037-z</pub-id>
  <?supplied-pmid 16990992?>
  <pub-id pub-id-type="pmid">16990992</pub-id>
 </mixed-citation>
</ref>
